The products of the modern biotechnology industry are built upon basic science research. Modern medical and academic institutions are increasingly looking for ways to commercialize scientific discoveries. More researchers than ever before are considering the transition from academia to industry, and many are thinking about building companies around their work. How do we identify what findings and technologies are appropriate targets for commercialization? How can we best form partnerships between academia, industry, and medicine to benefit from their respective strengths in innovation, commercialization, and improving the lives of patients? What should young researchers who are interested in entrepreneurship and science do to prepare for a career at the nexus of biotechnology and business?
In this session, these challenges will be discussed with academics and industry members who have successfully navigated the transition from bench to market in their careers. Funding mechanisms for both industry and academia will be explored. Routes by which academics may partner with commercial entities to enable research as well as means to raising money for an early-career bio-entrepreneur will be discussed with experts at all stages of the scientific pipeline, from startup founder to biotech exec, as well as with funding experts including venture capitalists, angel investors, and startup incubator leadership.